Company · CIK 0001844417 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Estrella Immunopharma, Inc. · ESLA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 MForm 4 → | Aug 26, 7:23 pm EDT | Cheng LiuCEO, Director | 100,000 | $0.815 | $81,500 | 397,437 | — | |
| Aug 18, 2026 MForm 4 → | Aug 25, 9:55 pm EDT | Jiandong XuChief Financial Officer | 100,000 | $0.815 | $81,500 | 365,488 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 MForm 4 → | Aug 26, 7:23 pm EDT | Cheng LiuCEO, Director | 100,000 | — | — | 900,000 | — | |
| Aug 18, 2026 MForm 4 → | Aug 25, 9:55 pm EDT | Jiandong XuChief Financial Officer | 100,000 | — | — | 390,796 | — | late |